Control of Blood Loss During Caesarean Section

NCT01412073 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Complications; Cesarean Section

Interventions

DRUG: oxytocin
DRUG: Misoprostol

Sponsor

Cairo University